Blebea, N.-M.; Pușcașu, C.; Hancu, G.; Stăniguț, A.M.; Chiriță, C.
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease. Pharmaceuticals 2025, 18, 890.
https://doi.org/10.3390/ph18060890
AMA Style
Blebea N-M, Pușcașu C, Hancu G, Stăniguț AM, Chiriță C.
Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease. Pharmaceuticals. 2025; 18(6):890.
https://doi.org/10.3390/ph18060890
Chicago/Turabian Style
Blebea, Nicoleta-Mirela, Ciprian Pușcașu, Gabriel Hancu, Alina Mihaela Stăniguț, and Cornel Chiriță.
2025. "Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease" Pharmaceuticals 18, no. 6: 890.
https://doi.org/10.3390/ph18060890
APA Style
Blebea, N.-M., Pușcașu, C., Hancu, G., Stăniguț, A. M., & Chiriță, C.
(2025). Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease. Pharmaceuticals, 18(6), 890.
https://doi.org/10.3390/ph18060890